The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Rudnic Edward M since year 2005.
The trader's CIK number is 1263483.
At the time of this reporting, Rudnic Edward M is the President and CEO of
Advancis Pharmaceutical Corp
(stock ticker symbol AVNC).
Stock purchases, sales, and option exercises reported by Rudnic Edward M since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-11-26
MBRK
Advancis Pharmaceutical Corp
Sale
11,400
1.10
12,597
2007-11-20
MBRK
Advancis Pharmaceutical Corp
Sale
5,000
1.15
5,733
2007-11-21
MBRK
Advancis Pharmaceutical Corp
Sale
4,300
1.09
4,687
2007-11-23
MBRK
Advancis Pharmaceutical Corp
Sale
2,400
1.04
2,508
2007-11-16
MBRK
Advancis Pharmaceutical Corp
Sale
1,300
1.18
1,534
2007-11-15
MBRK
Advancis Pharmaceutical Corp
Sale
5,400
1.21
6,534
2007-11-19
MBRK
Advancis Pharmaceutical Corp
Sale
10,200
1.18
12,036
2007-10-18
MBRK
Advancis Pharmaceutical Corp
Sale
12,600
1.43
18,018
2007-10-15
MBRK
Advancis Pharmaceutical Corp
Sale
7,700
1.60
12,281
2007-10-16
MBRK
Advancis Pharmaceutical Corp
Sale
9,000
1.54
13,905
2007-10-17
MBRK
Advancis Pharmaceutical Corp
Sale
10,700
1.49
15,943
2007-09-17
MBRK
Advancis Pharmaceutical Corp
Sale
13,100
2.22
29,147
2007-09-18
MBRK
Advancis Pharmaceutical Corp
Sale
26,900
2.24
60,340
2007-08-23
MBRK
Advancis Pharmaceutical Corp
Sale
11,000
2.36
25,940
2007-08-22
MBRK
Advancis Pharmaceutical Corp
Sale
16,000
2.37
37,912
2007-08-24
MBRK
Advancis Pharmaceutical Corp
Sale
13,000
2.30
29,899
2006-11-21
AVNC
Advancis Pharmaceutical Corp
Sale
10,000
4.07
40,679
2006-09-20
AVNC
Advancis Pharmaceutical Corp
Sale
40,000
5.61
224,376
2006-02-16
AVNC
Advancis Pharmaceutical Corp
Option Exercise
221,299
.50
111,755
2006-02-16
AVNC
Advancis Pharmaceutical Corp
Sale
110,000
1.83
201,457
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Rudnic Edward M
(President and CEO of Advancis Pharmaceutical Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
